Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

17.38

+0.60 (3.58%)

Aug 22, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2017 - 2018
Biopharmaceutical Products	886.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Products Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2017 - 2018
United States	886.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade